News Outlets Discuss Various Aspects Of COVID-19 Vaccine R&D, Availability, Licensing; Antibody Drug Access; Operation Warp Speed Leadership; Drug Shortages
CNBC: ‘Learn to live with the pandemic’: Physicians warn that a vaccine may not prevent Covid from becoming endemic (Meredith, 10/22).
The Hill: Azar says COVID-19 vaccine could be delivered to vulnerable people by January (Axelrod, 10/22).
NPR: How Will The Limited Supply Of Antibody Drugs For COVID-19 Be Allocated? (Harris, 10/21).
STAT: Blood plasma showed no benefit in Covid-19 patients in trial — a finding that could re-energize debate (Garde/Herper, 10/22).
STAT: ‘A matter of life and death’: Why a Brazilian lawmaker wants compulsory licensing for Covid-19 products (Silverman, 10/22).
STAT: Democrats want to fire Warp Speed’s Moncef Slaoui and overhaul the program. But if Biden wins, should he? (Florko, 10/22).
STAT: As Covid-19 intensifies, shortages of staple drugs may grow worse (Silverman, 10/21).
Washington Post: Moderna’s coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities (Johnson, 10/22).